Part 1/10:
The Rise of GLP-1 Drugs: Understanding the OIC Phenomenon
In recent years, GLP-1 drugs, particularly OIC (commercially known as Ozempic), have surged in popularity and become a cultural phenomenon in the United States. Reports indicate that approximately 1 in 8 U.S. adults have tried these medications, prompting an explosion of discourse online and in the media about their effects, from weight loss and potential fertility benefits to serious side effects such as hair loss and gastrointestinal issues. The Danish pharmaceutical company behind OIC has seen its valuation soar, now surpassing that of Coke and McDonald's combined. But are we fully aware of what these drugs entail?